Trial intelligence / Profile preview

Impact of stem cell donation using G-CSF mobilization vs bone marrow harvest on unrelated donors

2007-006301-24Phase 4Completed

Sponsor
University College London
Start
Dec 2007
Modality
Cytokines & Interferons → Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, open-label trial of lenograstim (2 arms), sponsored by University College London. Primary endpoint: Genetic clonal aberrations in chromosomes 7, 8, and 17. Started Dec 2007; status: completed.

02

Drugs

lenograstim

Beyond the preview

Go deeper on 2007-006301-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-006301-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call